3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2
Osteoporosis
1
Myocardial Ischemia
1
Heart Diseases
1
Estrogen Receptor Positive Breast Cancer
1
Coronary Disease
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Bone Diseases
1
Interventions
Fulvestrant
2
vistusertib
1
proto-oncogene protein c-fes-fps
1
capivasertib
1
Transurethral Resection of Bladder
1
Hydroxychloroquine
1
Everolimus
1
Estrogens
1
Estradiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Estrogen Receptor Positive Breast Cancer
×
Estrogens
×
Breast
×
Clear all
NCT02238808
2025-06-26
PRESTO
AHS Cancer Control Alberta
Phase 2
Active not recruiting
19 enrolled